Volume 20, Issue 4 , Pages 225-231, August 2007
Findings Associated with Recurrence of Bacterial Vaginosis among Adolescents Attending Sexually Transmitted Diseases Clinics
Abstract
Study Objective
Bacterial vaginosis (BV) is a common infection and has been associated with adverse health outcomes, including preterm birth, pelvic inflammatory disease (PID), and acquisition of HIV. There are limited data on recurrent BV in adolescents. A relationship between the frequency of BV recurrence and specific risk factors might shed light on the pathophysiology of BV and lead to targeted interventions.
Methods
Design: Record-based historical clinic study. Setting: Adolescent visits to two sexually transmitted disease (STD) clinics between 1990 and 2002. Participants: 254 girls who had ≥ 2 episodes of BV and at least 3 clinical visits, matched on clinic attendance frequency to 254 girls with only 1 documented BV episode and 254 girls with no history of BV.
Main Outcome Measure
Risk factor differences between groups.
Analysis
Multinomial logistic regression with robust estimator of the standard errors, accounting for repeated measures.
Results
5,977 adolescent girls visited the clinics. 1509 (25%) had at least one episode of BV; of those, 303 (19.9%) had 2 or more BV episodes. Girls with a history of 1 BV episode and girls with a history of 2 or more BV episodes were more likely to be infected with Trichomonas vaginalis [OR 1.77, 95% CI: 1.17–2.67, OR 1.56, 95% CI: 1.05–2.34] and be diagnosed with PID [OR 1.50, 95% CI: 1.02–2.22, OR 2.05, 95% CI: 1.41–2.98] compared to girls with no BV history, respectively. Girls with a history of BV were also more likely to report active oral sex and lack of contraceptive use.
Conclusion
Adolescent girls who attend STD clinics have a high prevalence of BV. Although the association between BV and PID is not clearly causal, when one condition is diagnosed, evaluation and counseling for the other may reduce recurrence and sequelae.
Key Words: Bacterial vaginosis, Recurrent, Pelvic inflammatory disease, Adolescent sexually transmitted disease
To access this article, please choose from the options below
This research was supported by National Institute of Allergy and Infectious Diseases grants T32 A1050056 (RMB), R03 A1061131 (JMZ), K24 A1001633 (JMZ), National Institute of Child Health and Human Development grant K23 HD047395 (KGG) and a NIH Intramural Research Training Award (RMB).
PII: S1083-3188(06)00342-1
doi:10.1016/j.jpag.2006.11.009
© 2007 North American Society for Pediatric and Adolescent Gynecology. Published by Elsevier Inc. All rights reserved.
Volume 20, Issue 4 , Pages 225-231, August 2007
